The role of nitric oxide in the pathogenesis of Chagas disease.
about
Modulation of immune response in experimental Chagas diseasePlasmodium cellular effector mechanisms and the hepatic microenvironmentThe role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infectionNew drugs for neglected infectious diseases: Chagas' disease.Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity.Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease.Trypanosoma cruzi infection in genetically selected mouse lines: genetic linkage with quantitative trait locus controlling antibody response.Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis.Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury.Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.A parent-of-origin effect determines the susceptibility of a non-informative F1 population to Trypanosoma cruzi infection in vivo.A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.Mast cell function and death in Trypanosoma cruzi infection.MIF synergizes with Trypanosoma cruzi antigens to promote efficient dendritic cell maturation and IL-12 production via p38 MAPK.Pathogenesis of malaria and clinically similar conditions.Enteric Neuronal Damage, Intramuscular Denervation and Smooth Muscle Phenotype Changes as Mechanisms of Chagasic Megacolon: Evidence from a Long-Term Murine Model of Trypanosoma cruzi InfectionIn vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donorsCombination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease.Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infectionThe Aryl Hydrocarbon Receptor Modulates Production of Cytokines and Reactive Oxygen Species and Development of Myocarditis during Trypanosoma cruzi Infection.MnSODtg mice control myocardial inflammatory and oxidative stress and remodeling responses elicited in chronic Chagas disease.Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donorsThe effects of nitric oxide on the immune system during Trypanosoma cruzi infection.Trypanosoma cruzi-Derived Neurotrophic Factor: Role in Neural Repair and Neuroprotection.Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice.Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytesEbi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven InflammationPerforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.DNA repair BER pathway inhibition increases cell death caused by oxidative DNA damage in Trypanosoma cruzi.Response to Trypanosoma cruzi by Human Blood Cells Enriched with Dentritic Cells Is Controlled by Cyclooxygenase-2 Pathway.Protein 3-nitrotyrosine formation during Trypanosoma cruzi infection in mice.Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.
P2860
Q27022885-8D1AECFE-4ED8-44E1-A0B8-A57B5CDB1D98Q28081143-A6285EBE-A809-4F1D-9869-032A35A6BBA0Q33535979-7BC26715-2BD1-4768-BC7B-82D1DB5E672CQ33870393-09D369C4-3071-43DF-9601-6E6B28272762Q33870401-7A51163C-A1F2-4B48-8FD2-AE368025CB87Q34040573-A55E9258-B6F4-41BF-80EF-489F1F29C461Q34096517-810BB6C1-9524-40CA-B3F2-B517D627D17FQ34124960-25296F67-75A3-45DD-9726-2A49B1E0E109Q34271214-6162B60C-5704-4285-AE42-E3AF53289DF4Q34531351-1CD7E1B0-1BC2-460C-AF81-C15956A4F2DDQ34586880-5412EAD1-DA0F-419B-8C1D-482B716E4333Q35009081-4E8A9AD6-B9FD-4A4E-870D-816630DF1B5EQ35235793-A54CA41F-5520-4B4B-86BC-36A4CC6EEBADQ35565161-44A55105-6DBF-4214-909E-00C045F09068Q35838590-E47DEF51-A390-4DEC-A952-B39CC694FE44Q35979730-444DBD0D-6437-4802-8238-3D1433FEC613Q35995235-51F62CA1-18FE-4E7C-9326-C11964D5A538Q37023164-4B17B99C-3181-4197-80EC-1A7CDA954A2BQ37190915-BAE72BDF-28EF-4D9C-9E6A-DD101B5CE4E9Q37215305-F948B008-FAF3-4AF3-8DB2-C96E605E48D9Q37287238-F2120882-21A4-4FD3-ABE1-306FA0F9E223Q37328752-889D7EE0-1A20-4FD8-AF12-4970673EF661Q37392826-1DBBA3B4-4818-48B4-87A1-42C3692FE741Q37597063-BD9598C1-F71C-4B61-87D1-A7B6AA62CEBAQ37875699-373CFD34-2D3D-41D2-B0AB-7CD2A209BF63Q41308213-D5F858A4-6ABC-4A29-A5C2-360A78684535Q42152162-D0F4BD18-C7CC-4189-A4FF-EA298DE59EA3Q42369872-3D2ECDDF-6ACE-4F56-A25E-D2983C6529A2Q43251669-9DC31DE9-4473-413A-B5ED-B67B9193B2EAQ43623255-D169F82C-AED5-4129-884A-77083CC885B5Q44174009-119CCF29-6D3E-42F5-A40C-35B417B1CF5CQ46815401-FB8455D8-570A-467E-9E54-72AAEA1F308EQ54534950-2EDDBE9A-3D32-4208-9A3F-D77EADD9B30F
P2860
The role of nitric oxide in the pathogenesis of Chagas disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The role of nitric oxide in the pathogenesis of Chagas disease.
@ast
The role of nitric oxide in the pathogenesis of Chagas disease.
@en
type
label
The role of nitric oxide in the pathogenesis of Chagas disease.
@ast
The role of nitric oxide in the pathogenesis of Chagas disease.
@en
prefLabel
The role of nitric oxide in the pathogenesis of Chagas disease.
@ast
The role of nitric oxide in the pathogenesis of Chagas disease.
@en
P356
P1476
The role of nitric oxide in the pathogenesis of Chagas disease
@en
P2093
Fabiana S Machado
Gislaine A Martins
P304
P356
10.2741/1012
P50
P577
2003-05-01T00:00:00Z